BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1525262)

  • 1. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate.
    Haagen L; Brock A
    Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):391-5. PubMed ID: 1525262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
    Gan KN; Smolen A; Eckerson HW; La Du BN
    Drug Metab Dispos; 1991; 19(1):100-6. PubMed ID: 1673382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polymorphic paraoxonase/arylesterase isozymes of human serum.
    La Du BN; Eckerson HW
    Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase polymorphism in rabbits.
    Zech R; Severin RM; Chemnitius JM; Nebendahl K
    Chem Biol Interact; 1999 May; 119-120():283-8. PubMed ID: 10421463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human serum paraoxonase/arylesterase polymorphism.
    Eckerson HW; Wyte CM; La Du BN
    Am J Hum Genet; 1983 Nov; 35(6):1126-38. PubMed ID: 6316781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous monitoring of arylesterase in human serum.
    Lorentz K; Wirtz W; Weiss T
    Clin Chim Acta; 2001 Jun; 308(1-2):69-78. PubMed ID: 11412818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esterolytic activity of blood serum in infants with hypertrophic pyloric stenosis.
    Szafran Z; Nowak J; Szafran H; Janik A
    J Clin Chem Clin Biochem; 1979 May; 17(5):321-4. PubMed ID: 469469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192).
    Nakanishi M; Takanami Y; Maruyama T; Murata M; Motohashi Y; Nakano S; Uchida K; Maruyama C; Kyotani S; Tsushima M
    J Atheroscler Thromb; 2003; 10(6):337-42. PubMed ID: 15037822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat inactivation of paraoxonase and arylesterase activities in human and rabbit serum.
    Simeon V; Pavković E
    Chem Biol Interact; 1993 Jun; 87(1-3):103-7. PubMed ID: 8393733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the serum paraoxonase/arylesterase polymorphism in a Turkish population.
    Karakaya A; Suzen S; Sardas S; Karakaya AE; Vural N
    Pharmacogenetics; 1991 Oct; 1(1):58-61. PubMed ID: 1668963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of Q192R polymorphism of paraoxonase 1 by using non-toxic substrate p-nitrophenylacetate.
    Mogarekar MR; Chawhan SS
    Indian J Hum Genet; 2013 Jan; 19(1):71-7. PubMed ID: 23901196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method for the determination of arylesterase activity in human serum using simulated body fluid.
    Nus M; Sánchez-Muniz FJ; Sánchez-Montero JM
    Atherosclerosis; 2006 Sep; 188(1):155-9. PubMed ID: 16297389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver.
    Jewell C; Ackermann C; Payne NA; Fate G; Voorman R; Williams FM
    Drug Metab Dispos; 2007 Nov; 35(11):2015-22. PubMed ID: 17664252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.
    Ortigoza-Ferado J; Richter RJ; Hornung SK; Motulsky AG; Furlong CE
    Am J Hum Genet; 1984 Mar; 36(2):295-305. PubMed ID: 6324579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New chromogenic and fluorogenic substrates for the determination of butyrylcholinesterase and arylesterase activities.
    Nozawa M; Tanizawa K; Kanaoka Y
    J Pharmacobiodyn; 1980 Jul; 3(7):321-7. PubMed ID: 7205543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular weight and substrate characteristics of human serum arylesterase following purification by immuno-affinity chromatography.
    Tanaka-Kawai H; Yomoda S
    Clin Chim Acta; 1993 Jun; 215(2):127-38. PubMed ID: 8403430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase.
    Rodrigo L; Gil F; Hernández AF; Pla A
    Chem Biol Interact; 1999 May; 119-120():263-75. PubMed ID: 10421461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.
    Furlong CE; Richter RJ; Seidel SL; Costa LG; Motulsky AG
    Anal Biochem; 1989 Aug; 180(2):242-7. PubMed ID: 2479288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity and interrelationship of intermediates in the hydrolysis of p-nitrophenyl acetate catalysed by chymotrypsin.
    MARINI MA; HESS GP
    Nature; 1959 Jul; 184():113-4. PubMed ID: 14421150
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel thermostable arylesterase from the archaeon Sulfolobus solfataricus P1: purification, characterization, and expression.
    Park YJ; Yoon SJ; Lee HB
    J Bacteriol; 2008 Dec; 190(24):8086-95. PubMed ID: 18931117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.